Engine: Phase III Randomized Study of Enzastaurin/R-CHOP Versus Placebo/R-CHOP in Frontline High Risk Diffuse Large B Cell Lymphoma Patients with Novel Genomic Biomarker DGM1 - Zhu, Jun; Nowakowski, Grzegorz; Zhang, Qingyuan; Brody, Joshua; Sun, Xiuhua; Maly, Joseph; Song, Yuqin; Song, Yongping; Lue, Jennifer Kimberly; Luo, Wen; Zhang, Lei; Han, Isabel; et al. (Blood, 2019)